197 related articles for article (PubMed ID: 21094191)
81. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
[TBL] [Abstract][Full Text] [Related]
82. Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil.
Alanazi FK; Haq N; Radwan AA; Alsarra IA; Shakeel F
Pharm Dev Technol; 2015 May; 20(3):266-70. PubMed ID: 24266739
[TBL] [Abstract][Full Text] [Related]
83. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.
Shi J; Zhang H; Wang L; Li L; Wang H; Wang Z; Li Z; Chen C; Hou L; Zhang C; Zhang Z
Biomaterials; 2013 Jan; 34(1):251-61. PubMed ID: 23069706
[TBL] [Abstract][Full Text] [Related]
84. Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.
Zhigaltsev IV; Winters G; Srinivasulu M; Crawford J; Wong M; Amankwa L; Waterhouse D; Masin D; Webb M; Harasym N; Heller L; Bally MB; Ciufolini MA; Cullis PR; Maurer N
J Control Release; 2010 Jun; 144(3):332-40. PubMed ID: 20202473
[TBL] [Abstract][Full Text] [Related]
85. Gold nanoparticles capped with benzalkonium chloride and poly (ethylene imine) for enhanced loading and skin permeability of 5-fluorouracil.
Safwat MA; Soliman GM; Sayed D; Attia MA
Drug Dev Ind Pharm; 2017 Nov; 43(11):1780-1791. PubMed ID: 28581826
[TBL] [Abstract][Full Text] [Related]
86. Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles.
Hitzman CJ; Wattenberg LW; Wiedmann TS
J Pharm Sci; 2006 Jun; 95(6):1196-211. PubMed ID: 16639722
[TBL] [Abstract][Full Text] [Related]
87. New Trends in Liposome-based Drug Delivery in Colorectal Cancer.
Krajewska JB; Bartoszek A; Fichna J
Mini Rev Med Chem; 2019; 19(1):3-11. PubMed ID: 30179131
[TBL] [Abstract][Full Text] [Related]
88. Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery.
Kheoane PS; Enslin GM; Tarirai C
Drug Deliv Transl Res; 2023 May; 13(5):1358-1371. PubMed ID: 36443635
[TBL] [Abstract][Full Text] [Related]
89. Enhanced liver targeting by synthesis of N1-stearyl-5-Fu and incorporation into solid lipid nanoparticles.
Yu BT; Sun X; Zhang ZR
Arch Pharm Res; 2003 Dec; 26(12):1096-101. PubMed ID: 14723346
[TBL] [Abstract][Full Text] [Related]
90. Development of a copper-clioquinol formulation suitable for intravenous use.
Wehbe M; Malhotra AK; Anantha M; Lo C; Dragowska WH; Dos Santos N; Bally MB
Drug Deliv Transl Res; 2018 Feb; 8(1):239-251. PubMed ID: 29247315
[TBL] [Abstract][Full Text] [Related]
91. DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation.
Leung AWY; Chen KTJ; Ryan GM; Anantha M; Wretham N; Nosrati Z; Heroux D; Wang L; Chow N; Dai Z; Bally MB
J Control Release; 2022 May; 345():75-90. PubMed ID: 35259461
[TBL] [Abstract][Full Text] [Related]
92. Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells.
Petrilli R; Eloy JO; Lopez RF; Lee RJ
Anticancer Agents Med Chem; 2017; 17(2):301-308. PubMed ID: 27225449
[TBL] [Abstract][Full Text] [Related]
93. Development of intravaginal rod insert bearing liposomal raloxifene hydrochloride and Leuprolide acetate as a potential carrier for uterine targeting.
Patel A; Dhande R; Thakkar H
J Pharm Pharmacol; 2021 Mar; 73(5):653-663. PubMed ID: 33772288
[TBL] [Abstract][Full Text] [Related]
94. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
Webb MS; Harasym TO; Masin D; Bally MB; Mayer LD
Br J Cancer; 1995 Oct; 72(4):896-904. PubMed ID: 7547237
[TBL] [Abstract][Full Text] [Related]
95. Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid-polymer hybrid nanoparticles.
Fu Q; Wang J; Liu H
Drug Deliv; 2020 Dec; 27(1):1535-1543. PubMed ID: 33118428
[TBL] [Abstract][Full Text] [Related]
96. New formulation of 5-fluorouracil in microspheres reduces toxicity in mice.
Hagiwara A; Sakakura C; Tsujimoto H; Ohgaki M; Imanishi T; Yamazaki J; Sawai K; Takahashi T; Yamamoto A; Muranishi S; Tabata Y; Ikada Y
Anticancer Drugs; 1996 Sep; 7(7):780-4. PubMed ID: 8949990
[TBL] [Abstract][Full Text] [Related]
97. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.
Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ
Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259
[TBL] [Abstract][Full Text] [Related]
98. Liposomes modified with cyclic RGD peptide for tumor targeting.
Dubey PK; Mishra V; Jain S; Mahor S; Vyas SP
J Drug Target; 2004 Jun; 12(5):257-64. PubMed ID: 15512776
[TBL] [Abstract][Full Text] [Related]
99. Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia.
Tan KB; Ling LU; Bunte RM; Chng WJ; Chiu GN
Nanomedicine (Lond); 2014 Aug; 9(11):1665-79. PubMed ID: 24294981
[TBL] [Abstract][Full Text] [Related]
100. 5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment.
Yusefi M; Lee-Kiun MS; Shameli K; Teow SY; Ali RR; Siew KK; Chan HY; Wong MM; Lim WL; Kuča K
Carbohydr Polym; 2021 Dec; 273():118523. PubMed ID: 34560940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
